AURA

AURA BIOSCIENCES INC

AURA·05153U107·US·Common Stock·Healthcare - Biotechnology-Activist

AURA (AURA BIOSCIENCES INC) is held by 76 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($32.7M), BlackRock, Inc. ($24M), VANGUARD CAPITAL MANAGEMENT LLC ($15M). Net institutional sentiment: Mixed.

76
Holders
Avg rating(18 Elite)
$142.5M
Total Value
55% (79)
Fund Consensus
39 buying - 32 selling
AURASmart Money Verdict
View all
Held by 76 funds
18 elite
Who's Trading
ActivistCYChen Yu9.9%May 12, 2026
ActivistMAMatrix Capital Management Company LP0.0%May 11, 2026
InsiderMLMatrix Capital Management Company, LPSell $39.0MMay 7, 2026
InsiderKCKilroy ConorSell $82KApr 16, 2026
InsiderDEde los Pinos ElisabetSell $241KFeb 17, 2026
InsiderHJHopkins Janet JillSell $103KFeb 17, 2026
InsiderPMPlavsic MarkSell $80KFeb 17, 2026
InsiderEAElazzouzi AmySell $43KFeb 17, 2026
ActivistALAdvent Life Sciences LLP3.3%Feb 17, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.6.3%Feb 13, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
4.9M$32.7M0.1%-39.55%
0
Increased
3.6M(+0.7%)$24M0.0%-12.72%
29
New
2.2M$15M0.0%+9.62%
39
Decreased
2.1M(-5.7%)$13.9M0.0%-12.56%
0
Increased
1.3M(+4.4%)$8.8M0.0%-26.02%
29
Increased
1.1M(+77.8%)$7.3M0.0%+15.05%
42
Increased
964,670(+4.1%)$6.5M0.0%-15.04%
28
Increased
558,158(+7.8%)$3.7M0.0%-14.08%
29
New
557,654$3.7M0.0%+9.62%
37
Increased
430,522(+4.3%)$2.9M0.0%-31.74%
27
Decreased
415,191(-6.2%)$2.8M0.0%-33.72%
0
New
397,160$2.7M0.0%+9.62%
36
New
391,334$2.6M0.0%+9.62%
36
Increased
224,041(+2.6%)$1.5M0.0%-3.00%
26
Increased
178,726(+27.7%)$1.2M0.0%-3.68%
31
Decreased
127,543(-9.5%)$853,2630.0%-12.98%
0
Decreased
125,356(-24.1%)$838,6320.0%+15.09%
0
Decreased
118,904(-30.7%)$795,4670.0%-11.38%
0
Decreased
102,100(-29.7%)$683,0490.0%-0.25%
0
Decreased
99,433(-7.9%)$665,2060.0%-35.88%
0

Showing 1-20 of 79

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used